Long-acting injectable antipsychotic in first-episode schizophrenia: The EONKCS Study

被引：0
|
作者：
Chiliza, B. [1 ]
Asmal, L. [1 ]
Emsley, R. [1 ]
机构：
[1] Univ Stellenbosch, Dept Psychiat, Cape Town, South Africa
来源：
SOUTH AFRICAN JOURNAL OF PSYCHIATRY | 2014年 / 20卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：97 / 97
页数：1
相关论文
共 50 条
  • [41] Long-acting antipsychotic medication as first-line treatment of first-episode psychosis with comorbid substance use disorder
    Abdel-Baki, Amal
    Thibault, Dominic
    Medrano, Sofia
    Stip, Emmanuel
    Ladouceur, Martin
    Tahir, Ramzan
    Potvin, Stephane
    EARLY INTERVENTION IN PSYCHIATRY, 2020, 14 (01) : 69 - 79
  • [42] Choice of antipsychotic to treat first-episode schizophrenia
    Taylor, David
    LANCET PSYCHIATRY, 2017, 4 (09): : 653 - 654
  • [43] Effectiveness of antipsychotic treatments in first-episode schizophrenia
    Tiihonen, J
    Wahlbeck, K
    Lönnqvist, J
    Klaukka, T
    Ioannidis, JPA
    Volavka, J
    Haukka, J
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S480 - S480
  • [44] NEW RESEARCH IN PSYCHOPHARMACOLOGIC INTERVENTIONS FOR ADHERENCE: A PROSPECTIVE STUDY OF LONG-ACTING RISPERIDONE VS. ORAL SECOND-GENERATION ANTIPSYCHOTIC IN FIRST-EPISODE SCHIZOPHRENIA
    Weiden, Peter Joseph
    Schooler, N. R.
    Sunakawa, A.
    Weedon, J.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 353 - 353
  • [45] Comparative Effectiveness of Risperidone Long-Acting Injectable vs First-Generation Antipsychotic Long-Acting Injectables in Schizophrenia: Results From a Nationwide, Retrospective Inception Cohort Study
    Nielsen, Jimmi
    Jensen, Signe O. W.
    Friis, Rasmus B.
    Valentin, Jan B.
    Correll, Christoph U.
    SCHIZOPHRENIA BULLETIN, 2015, 41 (03) : 627 - 636
  • [46] Factors associated with relapse in schizophrenia despite adherence to long-acting injectable antipsychotic therapy
    Alphs, Larry
    Nasrallah, Henry A.
    Bossie, Cynthia A.
    Fu, Dong-Jing
    Gopal, Srihari
    Hough, David
    Turkoz, Ibrahim
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2016, 31 (04) : 202 - 209
  • [47] Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia
    Kane, John M.
    McEvoy, Joseph P.
    Correll, Christoph U.
    Llorca, Pierre-Michel
    CNS DRUGS, 2021, 35 (11) : 1189 - 1205
  • [48] Effects of aripiprazole long-acting injectable antipsychotic on hospitalization in recent-onset schizophrenia
    Karlovic, Dalibor
    Silic, Ante
    Crnkovic, Danijel
    Peitl, Vjekoslav
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2021, 36 (02)
  • [49] Management of Schizophrenia with Long-Acting Injectable Antipsychotic Medications: An Assessment of the Educational Needs of Clinicians
    Citrome, Leslie
    Belcher, Emily
    Stacy, Sylvie
    Suett, Mark
    Mychaskiw, Marko
    Salinas, Gregory D.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2022, 18 : 111 - 123
  • [50] Long-Acting Injectable Antipsychotic Medications in Patients With Comorbid Schizophrenia and Substance Use Disorders
    Green, Alan I.
    JOURNAL OF DUAL DIAGNOSIS, 2012, 8 (01) : 62 - 63
12345